MEDVidi Review
GLP-1 weight-loss telehealth · Independently scored 4.8/10
Best for: paying per visit for a brand-name GLP-1 prescription that you fill at your own pharmacy
MEDVidi falls below our bar on disclosure. Read the breakdown below before you give it money.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the plan
Medication
Not stated
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
MEDvidi is a mental-health telehealth practice that also runs a weight-loss service, and it charges per visit instead of by subscription. The first consultation is $195, a follow-up is $159, and the two together are $249. Its clinicians can prescribe brand-name semaglutide (Wegovy, Ozempic, Rybelsus) and tirzepatide (Zepbound, Mounjaro) beside older weight-loss drugs, and the prescription goes to a pharmacy you choose. It is a different company from MEDVi.
Is MEDVidi legit?
Yes. MEDVidi is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 4.8/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a MEDVidi promo or coupon code?
We know of no promo or coupon code for MEDVidi. Coupon sites advertising "MEDVidi discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how MEDVidi compares on our rankings of the best weight-loss injection providers.
Vetted alternatives to MEDVidi
Editorial score · methodology
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Found
Best for: people who want clinician visits billed to commercial insurance, with compounded medication in the plan price
Editorial score · methodology
MEDVidi at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Zepbound, Wegovy
- What's included
- Consult
- Availability
- 35 states
- FDA status
- No FDA warning letters found
How MEDVidi scores
Six columns, each one computed from something MEDVidi has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
3.0/10There is no monthly price to compare, so Value is capped rather than scored against other sellers.
Effectiveness25%
5.0/10No medication list or price is available to score, so this is held at the midpoint. It is not a judgment on the drugs themselves.
User Experience15%
5.0/10Where this seller first shows a price is not known, so sign-up is held at the midpoint.
Trust & Safety15%
5.0/10No pharmacy is named for its prescriptions. There is no confirmed price before the medical intake. It lists the states it serves.
Accessibility10%
7.6/10Serves 35 of 50 states.
Support10%
5.0/10No published price, so what a price would include cannot be assessed. Held at the midpoint.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on MEDVidi
Last checked October 2026- Checked state coverage: 35 states
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for MEDVidi
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
Cancelling MEDVidi
Taken from the terms MEDVidi publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- None; each visit is paid for on its own
- Refund policy
- Full refund when you cancel at least 8 hours ahead; no refund once the visit has started
- Early-termination fee
- None
Medications MEDVidi lists
MEDVidi lists Wegovy, Ozempic, Zepbound, Mounjaro, Rybelsus, Saxenda, Trulicity, Contrave and Qsymia. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
In its favor
- The monthly price includes clinician visits
- We found no FDA warning letters issued to MEDVidi
Against it
- Serves only 35 states, so check that yours is one of them
- Ask which pharmacy fills the prescription before you pay, so you can check its license
What MEDVidi charges
There is no standard monthly price to quote for MEDVidi, so you cannot compare it with other sellers until you have been through an intake and received a quote. When you get one, ask for the ongoing monthly figure and what it includes, not the first-month rate and not a program total divided by its length. Before you pay, compare MEDVidi's cancellation terms with other sellers' cancellation and refund policies. MEDVidi is not alone in this: about a fifth of GLP-1 sellers publish no price at all.
What MEDVidi dispenses
MEDVidi prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market.
Safety and disclosure
MEDVidi tells you the 35 states it serves. We found no FDA warning letters issued to MEDVidi. The FDA publishes seven warning signs for telehealth medicine sellers, and they take a minute to run against MEDVidi. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You want to compare prices before spending time on an intake. There is no standard monthly price to compare.
- You need insurance to cover the cost. Check whether MEDVidi bills your plan before you start.
Our read
Whether MEDVidi is priced well is impossible to judge before an intake, because there is no standard price to compare. That does not rule it out, and plenty of legitimate sellers quote after intake, but it puts the comparison after you have spent the time, which is the wrong order for you as the buyer. WellMedRx is the nearest comparison we review, and worth reading alongside this.
The Bottom Line
MEDVidi falls below our bar on disclosure. Read the breakdown below before you give it money.
Before you pay MEDVidi
Check today's price, then start the intake.
Where MEDVidi is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these two counts, another seller does better.
- If you want a human checking in, not just a prescription, consider Found.
- If your state is outside the area this one covers, consider YourEra.
If none of these fits, our guide to alternatives to MEDVidi sets more sellers in the same category beside MEDVidi on price, states and what the price includes.
Frequently Asked Questions
How to check MEDVidi yourself
- We Read FDA's Register of Compounding Facilities. 43 of 100 Have Never Been Inspected.
- How to Get a GLP-1 Prescription
- FDA Warning Letters to Peptide Sellers: What FDA Has Cited, 2023 to 2026
Every seller that ships to your state, side by side: Connecticut, Kentucky, Mississippi, North Dakota, Oregon, Tennessee, Wisconsin, Wyoming and every other state.
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this MEDVidi review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
See MEDVidi's current pricing
Whether you qualify is a clinician's decision, made after your intake.